» Articles » PMID: 1971194

Two Identical Active X Chromosomes in Human Mammary Carcinoma Cells

Overview
Date 1990 Jun 1
PMID 1971194
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosome G-banding analysis of two human mammary carcinoma cell lines, Elco and MCF-7, showed the existence of two X chromosomes in both cell lines. To determine the state of activity of the X chromosomes, a methylation-sensitive restriction endonuclease, HpaII, was used to distinguish the active X from the hypermethylated, inactive X chromosome with a probe for the phosphogalactokinase locus by Southern blot hybridization. DNA digested with the restriction enzymes PstI and BstXI showed a band at either 1.05 or 0.9 kilobases. After HpaII digestion, a 50% reduction in intensity was observed in the female controls, whereas total reduction of the band was observed for the tumor cell lines and the male control. This indicates the absence of an inactive X and the presence of only active X chromosomes in the mammary carcinoma cell lines and the male control. To investigate the mechanisms involved in the alteration of the X chromosome composition and activity, restriction fragment length polymorphism analyses of seven additional X chromosome markers (L1.28, DX13, p52A, pX65H7, L782, pA13.RI, and pXG-12) were performed on the DNA isolated from the tumor cells and controls. Heterozygosity for at least one of the seven markers was detected in the six female controls whereas only homozygosity was detected for each marker in the tumor cell lines and the male control. These results indicate that the two active X chromosomes identified in each of the two tumor cell lines are identical, resulting from duplication or nondisjunction of the active X and loss of the inactive X chromosome.

Citing Articles

Oncogenes and tumor suppressor genes: functions and roles in cancers.

Dakal T, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V MedComm (2020). 2024; 5(6):e582.

PMID: 38827026 PMC: 11141506. DOI: 10.1002/mco2.582.


Establishing the Link between X-Chromosome Aberrations and Status, with Breast Cancer Patient Outcomes.

Caramia F, Speed T, Shen H, Haupt Y, Haupt S Cells. 2023; 12(18).

PMID: 37759468 PMC: 10526523. DOI: 10.3390/cells12182245.


Inactivation of X-linked tumor suppressor genes in human cancer.

Liu R, Kain M, Wang L Future Oncol. 2012; 8(4):463-81.

PMID: 22515449 PMC: 4369797. DOI: 10.2217/fon.12.26.


FOXP3 as an X-linked tumor suppressor.

Wang L, Liu R, Ribick M, Zheng P, Liu Y Discov Med. 2010; 10(53):322-8.

PMID: 21034673 PMC: 4500105.


BCoR-L1 variation and breast cancer.

Lose F, Arnold J, Young D, Brown C, Mann G, Pupo G Breast Cancer Res. 2007; 9(4):R54.

PMID: 17697391 PMC: 2206730. DOI: 10.1186/bcr1759.